Pathology of Minamata disease. With special reference to its pathogenesis

Acta Pathologica Japonica
|January 1, 1982
PubMed

Insights

Minamata disease, caused by methylmercury in seafood, damages the brain through direct neurotoxicity and impaired blood circulation. These mechanisms, neurotoxic and vascular, affect brain cortex neurons differently based on disease onset.

Area of Science:

  • Neuropathology
  • Toxicology
  • Environmental Health

Background:

  • Minamata disease is a severe neurological disorder caused by methylmercury (MeHg) poisoning.
  • Consumption of contaminated fish and shellfish leads to MeHg accumulation in the human body.
  • Pathological studies reveal widespread organ distribution and specific brain lesions.

Purpose of the Study:

  • To discuss neuropathological and metal-histochemical changes in Minamata disease.
  • To elucidate the mechanisms of brain cortex destruction in methylmercury poisoning.
  • To differentiate the roles of neurotoxic and vascular effects in disease progression.

Main Methods:

  • Pathological examination of human tissues.
  • Metal-histochemical analysis to trace methylmercury.
  • Correlation of pathological findings with clinical presentation (acute vs. chronic).

Main Results:

  • Methylmercury accumulates in various organs, with a predilection for the nervous system, especially the brain.
  • Two primary mechanisms of brain cortex damage identified: direct neurotoxicity and hypoxemic/anoxemic effects due to circulatory disturbance.
  • Vascular mechanisms (edema, circulation issues) are more prominent in acute/subacute cases, while neurotoxicity dominates chronic cases.

Conclusions:

  • Methylmercury causes significant neuropathology through direct neuronal damage and secondary effects on brain vasculature.
  • Understanding these dual mechanisms is crucial for diagnosing and managing Minamata disease.
  • The balance between neurotoxic and vascular effects influences the clinical manifestation and progression of the disease.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...